Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

1 results about "Glioblastoma" patented technology

A cancerous tumor which develops in the brain.

Glioblastoma multiforme targeting nano magnetic resonance contrast agent as well as preparation and application thereof

ActiveCN109125743AAchieving dual modality imagingImprove concentrationGeneral/multifunctional contrast agentsPolyethylene glycolTherapeutic effect
The invention relates to a glioblastoma multiforme targeting nano magnetic resonance contrast agent as well as preparation and application thereof. The magnetic resonance contrast agent consists of asmall molecule with a targeting combination function, a fluorescence indicator and a magnetic iron oxide nano carrier, wherein the small molecule with the targeting combination function is oligopeptide which has affinity with EGFRvIII which is highly expressed on the surface of a glioblastoma multiforme cell; the surface of the nano carrier is coated by the fluorescence indicator in a covalent linkage manner; the oligopeptide is connected with polyethylene glycol on surfaces of nanoparticles in the covalent linkage manner. The contrast agent can be administrated in an intravenous injection manner, the oligopeptide is combined with EGFRvIII which is highly expressed on the surface of a tumor cell, concentrated accumulation of the nano carrier at a tumor part is promoted, clinical treatmentprecision and security can be improved, and a noninvasive visible means are provided for treatment effect evaluation of tumor chemoradiotherapy and prognosis evaluation on patients.
Owner:AFFILIATED HUSN HOSPITAL OF FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products